Pharmicell signs ₩7.4bn electronic materials supply contract with Doosan

Pharmicell · KOSPI · 005690 · Oct 14, 2026 · Supply contracts

Pharmicell disclosed a supply contract for electronic materials with counterparty Doosan Corporation, which the filing reports as 6.5% of revenue. The contract amount is ₩7.4bn, with a period from Oct 13, 2026 to Dec 31, 2026.

Key facts

Contract nameElectronic materials supply contract
CounterpartyDoosan Corporation
Contract amount₩7.4bn
% of revenue (as reported)6.5%
Period startOct 13, 2026
Period endDec 31, 2026

Comparison

Amount as % of FY2025 revenue (calculated)6.5%
Revenue 2025₩114.1bn
Revenue 2024₩64.9bn
Revenue 2023₩56.2bn

Context

In the 12 months before this filing, Pharmicell filed 5 supply contracts totaling ₩36.3bn, and 1 of them was with this counterparty.

Key metrics

Supply contracts

Supply contracts, last 12 months₩39.6bn As of Oct 14, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5
Supply contracts vs prior-year revenue34.7% As of Oct 14, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)